CALVI, MICHELA
CALVI, MICHELA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Immune profiling identifies distinct immunological subtypes of Myelodysplastic Syndromes with prognostic and therapeutic relevance
2026 C. Di Vito, M. Calvi, E. Riva, M. Zampini, L. Dall’Olio, A. Merlotti, M. Ubezio, A. Russo, G. Maggioni, A. Frigo, L. Orlandi, E. Saba, D. Remondini, G. Castellani, M.G. Della Porta, D. Mavilio
Extracellular vesicle phenotypic patterns associated with CMV, EBV and HHV-6 reactivation after haploidentical transplantation with post-transplant cyclophosphamide
2026 G. Lia, C. Di Vito, S. Bruno, J. Mariotti, A. Melis, M. Calvi, L. Giaccone, A. Santoro, S. Bramanti, L. Castagna, A. Evangelista, D. Mavilio, B. Bruno
Disrupted Innate Lymphoid Cell Poiesis and Immune Dysfunction in Myelodysplastic Syndromes
2026 L. Orlandi, M. Calvi, A. Frigo, P. Marzano, A. Limonta, J. Mikulak, V. Menozzi, M.G. Della Porta, C. Di Vito, D. Mavilio
Single-cell profiling of dysfunctional NK cells in COVID-19: from immunization to acute infection and beyond
2026 A. Frigo, S. Terzoli, P. Marzano, N. Coianiz, M. Calvi, L. Orlandi, S. Balin, V. Cazzetta, A. Carletti, S. Della Bella, J. Mikulak, M. Tarkowski, M. Bonfanti, P. Ferrari, E. Ricciardelli, C. Peano, A. Riva, G. Testa, A. Voza, F. Calcaterra, C. Di Vito, D. Mavilio
PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease Progression
2026 V. Vallelonga, F. Gandolfi, M. Zampini, E. Riva, G. Maggioni, D. Ventura, E. Saba, A. Termanini, S. Polletti, E. Prosperini, L. Crisafulli, A. Campagna, I. Ferrari, N. Pinocchio, G. Todisco, S. Pedretti, M. Calvi, C. Di Vito, D. Mavilio, N. Mitro, F. Ficara, M.G. Della Porta, S.M.L. Ghisletti
Deciphering the role of immune system dysfunction in patients with Myelodysplastic Syndrome to refine the prognostic assessment and predict treatment response
2025 C. Di Vito, M. Calvi, E. Riva, M. Zampini, L. Dall’Olio, A. Merlotti, M. Ubezio, A. Russo, G. Maggioni, A. Frigo, L. Orlandi, E. Saba, D. Remondini, G. Castellani, G. Della Porta Matteo, D. Mavilio
Unveiling ILC-poiesis disruption in myelodysplastic syndromes
2025 L. Orlandi, M. Calvi, A. Frigo, M.G. Della Porta, C. Di Vito, D. Mavilio
A 36-antigen spectral flow cytometry panel to unravel human NK cell differentiation and education
2025 A. Frigo, L. Orlandi, V. Menozzi, M. Calvi, M. Di Sergio, G. Tettamanti, D.F. Lattuada, D. Manganaro, C. Di Vito, D. Mavilio
Disrupted innate lymphoid cell development shapes prognosis and therapy outcomes in myelodysplastic syndrome patients
2025 L. Orlandi, M. Calvi, A. Frigo, E. Riva, G. Maggioni, A. Russo, E. Saba, M. Ubezio, M. Giovanni Della Porta, C. Di Vito, D. Mavilio
Multi-methodologic dissection of human Natural Killer cell ontogenesis to study the contribution of unconventional NK cell subsets and other Innate Lymphoid Cells (ILCs)
2024 A. Frigo, P. Marzano, M. Calvi, L. Orlandi, S. Terzoli, C. Favazzi, K. Chiappetta, G. Grappiolo, M. Loppini, C. DI VITO, D. Mavilio
DECIPHERING THE ROLE OF IMMUNE SYSTEM DYSFUNCTION IN MYELODYSPLASTIC SYNDROMES CLASSIFICATION AND PROGNOSIS
2024 E. Riva, M. Calvi, M. Zampini, L. Dall’Olio, A. Merlotti, A. Russo, G. Maggioni, A. Frigo, E. Saba, E. Lugli, D. Remondini, G. Castellani, C. DI VITO, D. Mavilio, M.G.D. Porta.
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in Natural Killer cell ontogenesis: the development of an autologous Bone Marrow niche mimicking system
2024 A. Frigo, S. Terzoli, M. Calvi, N. Coianiz, M. Loppini, C. DI VITO, D. Mavilio
Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics
2024 S. Terzoli, P. Marzano, V. Cazzetta, R. Piazza, I. Sandrock, S. Ravens, L. Tan, I. Prinz, S. Balin, M. Calvi, A. Carletti, A. Cancellara, N. Coianiz, S. Franzese, A. Frigo, A. Voza, F. Calcaterra, C. Di Vito, S.A.M. Della Bella, J. Mikulak, D. Mavilio
Landscape of Immune Cell States and Ecosystems in Patients with Myelodysplastic Syndrome to Rene Prognostic Assessment and Predict Treatment Response
2024 E. Riva, M. Calvi, M. Zampini, L. Dall'Olio, A. Merlotti, A. Russo, G. Maggioni, L. Orlandi, A. Frigo, F. Ficara, L. Crisafulli, E. Sauta, S. D'Amico, E. Lugli, A. Campagna, M. Ubezio, C. Astrid Tentori, G. Todisco, L. Lanino, A. Buizza, D. Ventura, N. Pinocchio, E. Saba, A. Santoro, V. Santini, A.A. van de Loosdrecht, R.S. Komrokji, G. Garcia-Manero, P. Fenaux, L. Ades, U. Platzbecker, T. Haferlach, A. Medina Almeida, A.M. Zeidan, S. Kordasti, D. Remondini, G. Castellani, C. DI VITO, D. Mavilio, A. Matteo Giovanni Della Porta
PATTERN OF INNATE IMMUNITY IN PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROME (MDS) EITHER BEFORE ANDAFTER HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
2023 M. Calvi
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics
2023 S. Terzoli, P. Marzano, V. Cazzetta, R. Piazza, I. Sandrock, S. Ravens, L. Tan, I. Prinz, S. Balin, M. Calvi, A. Carletti, A. Cancellara, N. Coianiz, S. Franzese, A. Frigo, A. Voza, F. Calcaterra, C. DI VITO, S.A.M. DELLA BELLA, J. Mikulak, D. Mavilio
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in human Natural Killer cell ontogenesis
2023 A. Frigo, S. Terzoli, M. Calvi, P. Marzano, C. Favazzi, G. Grappiolo, M. Loppini, C. Di Vito, D. Mavilio
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics
2023 P. Marzano, S. Terzoli, V. Cazzetta, R. Piazza, I. Sandrock, S. Ravens, L. Tan, I. Prinz, S. Balin, M. Calvi, A. Carletti, A. Cancellara, N. Coianiz, S. Franzese, A. Frigo, A. Voza, F. Calcaterra, C. Di Vito, S.A.M. Della Bella, J. Mikulak, D. Mavilio
Relevance and heterogeneity of adaptive NK cells in the scenario of SARS-CoV-2: between vaccination and natural infection
2023 A. Frigo, S. Terzoli, M. Calvi, N. Coianiz, F. Calcaterra, C. DI VITO, D. Mavilio
The immunome profile of myelodysplastic syndrome patients defines different prognostic groups and shows a predictive potential to hypomethylating therapy
2023 M. Calvi, E. Riva, M. Zampini, L. Dall’Olio, A. Merlotti, A. Russo, G. Maggioni, A. Frigo, E. Saba, D. Remondini, G. Castellani, C. DI VITO, M. Giovanni Della Porta, D. Mavilio